3M Company (MMM) Earnings Call Transcript & Summary

June 3, 2021

New York Stock Exchange US Industrials Industrial Conglomerates conference_presentation 57 min

Earnings Call Speaker Segments

Brendan Luecke

analyst
#1

Good morning. My name is Brendan Luecke, and I'll be covering the multi-industry sector here at Bernstein. It's my pleasure to welcome all of you today to today's fireside chat with 3M. Thank you all for joining us. Before we dive in, I'd like to cover a few housekeeping items. As always, we're striving for an interactive session. So similar to last year, we'll be using Pigeonhole for Q&A. There's a link on the bottom -- on the left side of your screen to access Pigeonhole. It opens up a new window browser where you can submit questions. You can also vote on questions already submitted by pressing the triangle next to any question. So please go ahead and click that link now and feel free to start submitting questions for 3M right away. That way we can tailor the conversation to the areas of your interest. Finally, it's my great pleasure to introduce 3M. We're thrilled to have 3M back at the SDC for, I believe, it's the 12th year running. With me today is Mike Roman, 3M's Chairman and CEO; and Bruce Jermeland, Senior Vice President, Investor Relations. It's a real pleasure to have you both at SDC again this year. Bruce, I believe you had a quick say before we get started.

Bruce Jermeland

executive
#2

Sure. Thank you, Brendan. And it's great to be here today with everyone. Just want to remind today's audience that's listening in to today's discussion about our forward-looking statements. During today's discussion, we may make certain predictive statements that reflect our current views about our future performance and financial results. These statements are based on certain assumptions and expectations of future events that are subject to risks and uncertainties. Item 1A of our most recent Form 10-K lists some of the most important risk factors that could cause our actual results to differ from our predictions. So with that, I'll hand it off to Mike for some opening remarks.

Michael Roman

executive
#3

Thank you, Bruce, and good morning, Brendan. It's good to be with you today. Let me start with 2020. It was an unprecedented year, and we prioritized protecting our employees, fighting the pandemic from every angle and delivering for our customers and shareholders. And we delivered strong execution in the face of that. Then we started 2021 with a strong Q1, up 8%, broad-based organic growth across all businesses and geographic areas. Our team has been executing well. We posted record sales, robust cash flow and expanded margins and a double-digit increase in earnings per share. We are seeing and have seen the improvement in many of our end markets, encouraging signs, while others still remain below pre-pandemic levels. We also have seen and are working to address ongoing global supply chain disruptions due to COVID-19 and exacerbated by some trends due to the improving macroeconomic environment and things like winter storm Uri, all of which are impacting us and increasing the cost of doing business. Looking ahead, we expect continued strengthening of the global economy, though we expect the recovery to continue to be uneven as the pandemic and the rollout of vaccines and government policies evolve in different stages around the world. I would say I'm very confident in our business as we navigate this uncertainty. And with 1 quarter behind us, we maintained our full year guidance for organic growth, earnings per share and cash flow. Overall, I'm pleased with 3M's first quarter performance as we did drive strong growth, earnings and cash flow. And we're positioned for a successful 2021 and remain focused on delivering value for our customers and returns for our shareholders. With that, I'll turn it back to you, Brendan, and take your questions.

Brendan Luecke

analyst
#4

Excellent. Well, thank you so much, and we're looking forward to a great discussion here. I guess to kick it off, hard not to tackle, but it's been, what, 15 months or 573 years, I'm not sure which, since the pandemic began. What are your biggest learnings over the past 1.5 years? And how are you going to carry those forward as you sort of see the exit trajectory from the pandemic?

Michael Roman

executive
#5

Well, COVID really did have a transforming effect on how people live, work and communicate. And it impacted our employees, our customers broadly. Years worth of changes happening in months. Everybody talks about the accelerating effect of COVID on trends that were there prior to the pandemic and trends that emerged during the pandemic. I would say, for us, we responded to those accelerated trends in the middle of pandemic. And one of the ways we did that to help fight the pandemic from every angle, pivoting to manufacture, more respirators than ever before, more than a fourfold increase in our production capacity. And that helped us fight the pandemic, helped deliver more than 630 million N95 respirators in Q1 of 2021. It also is giving us lessons that we can apply more broadly. We're applying what we learned in that accelerated scale-up to new investments in growth priorities, in our indoor air quality solutions, our Filtrete brand solutions, in our biopharma filtration, which is high demand in supporting vaccines and therapeutics. It's also learnings in how we've responded to the pandemic that will carry forward how we help customers, getting closer to customers, finding new ways to connect with customers, helping them respond to the pandemic with innovation in products, also in new ways of working. And there are some things that will be changed as we go forward. Dental offices using more personal protective equipment than ever before, and we can help with that. So lessons in how we work even more closely with customers. The other partnership aspect of COVID, the learnings around how important partnerships are more than ever. And public-private partnerships in the middle of the pandemic were key. Partnering with other companies enabled us to do things in fighting the pandemic and also delivering for our customers better than ever before. And those are shifts that will stay with us. We'll carry that forward. And I would say, in the middle of the pandemic, there was an increased focus on the environment, ESG broadly, in particular, on the environment. And this is a great opportunity for us as a company to leverage our science, our innovation, how we can lead in really managing our operations, managing air, water and waste, really driving improved environmental stewardship. And we can innovate for our customers to help them do the same, areas like automotive electrification where we can help enable the electrification of the powertrain and electric vehicles in the automotive future. So there's a big focus and I would say an accelerated focus in that area as well. And then as we think about this summer and especially here in the U.S. as we make progress with vaccinations, we are returning more of our employees to the workplace. And we're thinking about the learnings from last year as well. How do we increase flexibility in how we work, taking the lessons from operating in our operations in the middle of the pandemic, as I mentioned, but also in our working remotely during the pandemic, how can we take advantage of those. And those will change how we work, create a lot more flexibility, a different kind of environment, not only in the U.S. but around the world.

Brendan Luecke

analyst
#6

Excellent. And I guess if we take it up a couple of levels, would you say that long term, your strategic priorities have shifted much to the pandemic? Or is it pretty much steady course?

Michael Roman

executive
#7

I would say the strength of the 3M model shined through in the middle of the pandemic. Our ability to respond to the changes in our end markets, and in some cases [indiscernible] that we saw incredible demand. And our operating model enabled us to -- in our -- I would say, our global manufacturing and building out of capabilities close to customers enabled us to respond quickly and really support our customers well during the uncertain times of the pandemic. So I think that reinforces -- there are always learnings and bringing more capabilities, but it reinforced that part of our strategy. We -- while we thought the pandemic and we managed some of the challenges in -- even in end markets that we saw downturns, we also continued to invest in the future. So we kept our eyes on what we know will deliver for our businesses and our customers as we go forward. So continue to invest where we saw growth opportunities, where we saw an opportunity for differentiated value from 3M's capabilities, our technologies, our manufacturing, our global capabilities, what we can do to innovate for our customers. So we continue to highlight not only our priority growth platforms that have been an important part of our investment in growth, also new emerging market trends that we saw coming through the pandemic in areas like home improvement, which continues to be a strong trend as we move forward, in areas like our personal protective equipment and where we can go in the future, in electronics and some of the growth segments that are emerging in electronics. Those are all areas that we made sure to continue to invest. So I see a strong opportunity for us to continue to leverage the strength of the 3M operating model and invest where we can make a difference with our innovation.

Brendan Luecke

analyst
#8

Fantastic. And I guess I'd love to talk macro briefly and then maybe sort of chat through the shape of the recovery as you see it playing out across your businesses. On the macro side, I'd imagine, given the breadth of your business, both across SKUs and geographies, you have a pretty privileged view of how the global economy is unevenly exiting from COVID. What are some of the highlights that you're seeing? What's deteriorating? What's stabilizing? What's taking off?

Michael Roman

executive
#9

Yes. Brendan, I mentioned it, we saw a strong start to the year in first quarter, and it was broad-based organic growth across our business groups, our geographic areas. That said, there were a few areas that were a bit stronger in Q1 than others. And even then, what we had expected coming into the quarter, including consumer electronics, really primarily due to strong demand in areas like TVs and tablets. We also saw, as I highlighted, a strong demand continuing and increasing in home improvement. People continue to invest in their homes. And we saw growth in our stationery and office supply business as students and workers started to return to schools and office. So it's -- we're seeing some of those trends continue in some cases and some of those start to improve and come back. One of the areas that we also talked about is what we're seeing in our health care business. We really focus there on how elective procedures are improving. And we saw at the end of 2020, early in January, with the increasing number of COVID cases, we saw elective procedures fall from where they had gone to in Q4, then they recovered. And they're somewhere around 80% to 85% of pre-pandemic levels, and we expect that to continue to improve as vaccinations and the improvement in the COVID pandemic progressed through the year. But they still remain below pre-pandemic levels as we go into Q2. I would say, other areas, we continue to see impact from the pandemic. We also see some challenges well documented and talked about the chip shortages impacting automotive build rates and some areas of electronics as well. So I would say no surprises so far as we get into Q2. We continue to monitor some of those areas that I highlighted, and we're continuing to watch those health care elective procedure volumes as we go. We also -- just to note, we're monitoring closely the demand for N95 respirators across multiple end markets, including health care, industrial, consumer and an area that we see demand, which is governments stockpiling for future pandemics. So we're monitoring that as we see the changes with the vaccinations and the reopening of the economies. So I don't -- I would say the one thing I'm certain of at this point is that end market trends are going to remain fluid and uncertain until we get further along in how it evolves.

Brendan Luecke

analyst
#10

Okay. Fantastic. That's useful color. So I guess shifting to sort of the business dynamics by segment. I mean there's a lot of puts and takes across the different pieces of the business. I'd just like to go deep in a couple of areas. So first, on Safety and Industrial, specifically on respirators, I mean, obviously, you guys have been delivering huge numbers in that area over the last 15 months. How do you think about the normalization of respirator sales, especially given kind of the wind-down in North America, while other geographies is out there nowhere close?

Michael Roman

executive
#11

Yes. Well, I highlighted a little bit of where we came into the year. We had ramped up our production capacity in 2020. We entered the year with a run rate of about 2.5 billion respirators annually, N95 respirators. In the first quarter, we distributed 630 million respirators globally. And demand for respirators remains strong. It's a very dynamic market right now. We're seeing demand changes in certain geographies post peak pandemic daily needs. In the U.S., for example, given the improving vaccination rates, health care-related demand has begun to moderate. This still remains materially higher than it was pre-pandemic. And as I mentioned, stockpile building and management is now balancing some of the slower real-time health care-related demand. We -- as we manage this shift, we are moving capacity to serve demand in industrial and consumer end markets in the U.S. In EMEA, we see -- Europe, Middle East, Africa, we see similar dynamics in health care. We also anticipate stockpile management will grow as we go through this year into 2022 as European governments are prioritizing that as part of their long-term plans. In other areas of the world, I would say it's -- we -- especially where you see continued elevated cold and infection rates, demand for health care use of N95s continues to be very robust, and we're directing our capacity to support that. So how long the strength of respirator demand continues will ultimately depend on how COVID really evolves and the success of the vaccine deployment globally and maybe some changes in -- potential changes in consumer behavior and how that proceeds. So I would just leave you, we're prepared to adjust our respirator output to meet the market demand. It's something we've managed in other X factors, nothing to the scale of a global pandemic. But it's something we're prepared to do, and we'll manage that as we see the shifts and changes in demand.

Brendan Luecke

analyst
#12

Fantastic. And then one other quick question on health care. Do you have any concerns around, say, price pressure emerging in the U.S. given the financial strain on a lot of hospitals, potential for accelerated consolidation?

Michael Roman

executive
#13

Well, we -- the focus for us, as I talked about, is how are hospitals doing and returning to normal operations. And elective procedures is an important measure of that. We -- and our Medical Solutions business, really, that drives a significant leading indicator for our demand. So as you look at hospitals, depending on how they decide to operate, where they go with their models, where they go with their organic and inorganic strategies, that will be the driver for us. So we watch that closely, and that's been improving. As I mentioned, it's improved out of the challenge that we saw at the beginning of Q1, improved as we went through the quarter. We expect that to continue to improve as we go through the year. The other area we look at is in our Health Information Systems business is we saw an impact in 2020 on capital budgets, IT -- health care IT budgets. We expect that to improve as hospitals get back to the business of elective procedures. So that's the focus for us as we go this year.

Brendan Luecke

analyst
#14

Okay. Fantastic. Transportation and Electronics. Obviously, a pretty big spread in the guide for this segment for '21. What should we be looking at to sort of get confidence around a narrower range across those businesses?

Michael Roman

executive
#15

Yes. Brendan, just -- we talked about this a bit at the Q4 earnings call when we talked about guidance for the year. The broader range of guidance for our Transportation and Electronics business really reflects the volatility of those electronics and automotive markets as we came out of 2020 into 2021. We hadn't anticipated the chip shortage impact in that, but that's another example of that. We also have -- that business also serves our oil and gas and energy industry, and looking at the outlook for that, that broader range for the year made good sense given the wide range of outlooks for those segments in those markets. Transportation and Electronics had a good start to the year. They're up 10% year-on-year in Q1. Despite the chip shortage and semiconductor supply chain constraints, Electronics grew high teens with strengths in semiconductor. We serve those semiconductor manufacturers. Data centers is a strong growth driver. Factory automation coming back. And then as I mentioned, we saw some strong demand in electronics -- consumer electronics, particularly tablets and TVs. Our automotive business also up strong in Q1, up 21%, outperforming global car and light truck builds, which were -- I think we revised to 15% for Q1. So that wider range, you can see the strong start is an example of the kinds of dynamics that we can see in those markets. So I'm pleased with the strong start. I think it's -- our teams are executing well in the face of that, some of the uncertainty that we're seeing there.

Brendan Luecke

analyst
#16

Okay. Fantastic. And then on Consumer, I mean how do you think about the puts and takes of return to work and back to school? Is there -- I mean, do you expect DIY to tail off or home improvement tail off as people spend less time at home? Are you assuming that we're pretty much back to normal this fall?

Michael Roman

executive
#17

Well, I mentioned, we continue to see strong growth in our home improvement business and end markets. Consumer is off to a good start to the year, up 8% organically in Q1. It was led by home improvement with strong demand for Filtrete air quality solutions. This is another one of those trends that was there before the pandemic. We were seeing strong demand in air quality solutions. The pandemic put an even stronger focus on that. We also see strong growth in our Command adhesives. And it's a focus on your -- personalizing your home and part of that home improvement view as well. So we see those trends continuing. That's something that we had before the pandemic. We think it will continue as we go forward. The improved growth in office supplies and stationery was partly due to, as I mentioned, the returning to the workplace and schools. It's also due to last year's comparison. So we'll see a year-over-year comparison to soft decline -- actually declining demand in 2020. So as we start lapping some of the work-from-home and school trends, we'll see some strength in that market as we go through the year. So we expect strength in home improvement. You see that improving year-over-year trends in office supply. And we continue to see strong growth opportunities in areas like home cleaning as well. So when you take all that, we see our consumer team executing well in the first quarter and continue to see opportunities for growth as we go forward.

Brendan Luecke

analyst
#18

Okay. Fantastic. What are you seeing in the channel across your businesses? Do you think that -- I mean would you attribute any of the recovery in Q1 to restocking or even overstock view of supply chain risks? Or do you think we're really looking at a reflection of end market recovery?

Michael Roman

executive
#19

I -- maybe the short answer is it's more of a reflection of end market recovery in what we're seeing. But I would say what we're seeing in the channel, I can give you a little bit of a view of that. We're seeing channel inventories pretty much in line with how analysts are looking at it. Your peers have written about this pretty broadly. We see, of course, challenges due to the growth trends, the COVID impact, things like the chip shortage and even winter storm Uri here in the U.S. Maybe by business, if you look at Safety and Industrial, I would characterize overall inventories remain relatively low with our channel partners as they're dealing with numerous supply issues during the recovery. N95 respirators, we've seen a moderate amount of inventory build in the U.S. at this point, mainly driven by the decline of COVID cases and the shift in the demand that I mentioned in health care and us shifting more of our focus back to industrial markets and even consumer segments. Transportation and Electronics, there's, of course, well-understood tightness in the semiconductor supply chain impacting both electronics and automotive end markets. Otherwise, I see the channel balanced with -- and working to stay balanced with that increasing demand. And health care channel inventories, they're pretty much on balance. And I think we are seeing -- example, in Oral Care was strong. We saw strong growth in Oral Care as we came through first quarter. We see some replenishment in the channel, really matching up with that increasing demand. So I think you kind of have 2 sides of it where you see moderating demand for us in something like respirators, in health care. We see some inventory build. Other places, it's pretty well balanced. And in some cases, where you see increasing growth, this tight supply working to catch up with that increasing growth.

Brendan Luecke

analyst
#20

Okay. Fantastic. And I've got a question from the audience here. Predates you a bit, so not entirely fair, but what do you think is the root cause for, I guess, let's say, uneven organic growth over the last decade? I mean 2019 is obviously a pretty big story there. And how do you plan to drive growth across all these businesses at 3M going forward?

Michael Roman

executive
#21

Well, it starts with the 3M fundamental strengths and what we do to drive growth, the model of 3M. And you look at -- our goals continue to be drive growth at or above the macro, deliver with that growth on our commitments in terms of cash flow and margins and earnings per share, value to our customers, return to our shareholders. That's the focus of us driving that growth. And our growth strategy is to leverage the fundamental strengths of 3M, leverage our innovation to create differentiated value and provide new opportunities for penetration of the markets we're part of. Today, increasing penetration and opportunities to also build new businesses. And it -- so innovation is central, and we've spent a lot of time with investors talking about what we're doing, where we're prioritizing our innovation. It's also important that we prioritize where we invest in innovation to attractive markets, prioritizing growth that are -- prioritizing markets which have growth that are better than average. It's very difficult to outgrow the macro if you are choosing markets that are growing slower than the macro, even if you can bring significant innovation. So that's part of what we've been focused on in our portfolio strategy, how do we prioritize, first and foremost, where we make organic investments and making sure that we're prioritizing investments in those higher-growth opportunities. And I highlighted a number of examples already. Priority growth platforms has been something we've been talking about for several years. We are also highlighting some of the areas that we came through 2020 that we saw additional opportunities, trends that provide high-growth market opportunities for our innovation. So that's what will drive the growth. And when you look at something like 2019 in the middle of it, part of that is markets that were challenging us and how we are aligned, where our priorities and investments are. And so as we go forward, it's critical we continue to focus on differentiated innovation to build new opportunities for penetration, share, new businesses in attractive markets. And that's what will give us the foundation for consistent growth in delivering on those goals to grow at or above the macro.

Brendan Luecke

analyst
#22

Excellent. And one other sort of retrospective question here. So as you look past -- if you look back over the last, say, 5 to 10 years, in what areas do you think 3M has been average or maybe lagging a little bit? And what are the areas of focus to address that? I mean, is it around R&D relative to marketing, maybe ERP? We spoke a lot about digital over the past couple of years. So if you think about the gaps you're trying to close, what would those be? And what's the plan forward?

Michael Roman

executive
#23

Brendan, it gets at something that I would say all companies are facing, and that is the world is a fast-changing place. The markets are fast changing. We saw, of course, acceleration of trends in the middle of COVID. Even outside of COVID, we see changes, ongoing changes in our marketplace, competitive world that we're part of. And I think what we are doing and where we're focused in some of our strategies is about leading through that change. So in addition to what I was highlighting in terms of prioritizing innovation where we can differentiate value for our customers in markets that are attractive, we're also building our capabilities end-to-end in our company. And digital capability is an important part of that. Something we've talked about over the years, I'm really excited about some of the progress we've made, where we are building capabilities. We launched a new operating model to take advantage of the transformation available to us in our digital capabilities. And we did that at the beginning of 2020, and we're seeing the benefits from that operating model. We're seeing the benefits from our digital strategy play out. Digital impacting our customers, and we have digital strategies focused on customers, digital focused on products and how we can bring digital solutions as part of what we leverage to solve customers' needs, digital operations and end-to-end -- taking advantage of data analytics, digital capabilities to build on the fundamental strengths we have in manufacturing, supply chain, customer experience, really positioning that. And that's a -- I think that was an important part -- the progress we made there was an important part of our ability to respond in 2020. There's much more to do there. There's much more opportunity there. And then we continue to build out our digital enterprise and our ERP and ecosystem capabilities. So I think those are areas that we've been focused on improving and continuing to advance. Those will help us lead through and take advantage of the changes that are taking place in our end markets and economies around the world.

Brendan Luecke

analyst
#24

Excellent. So within that digital, I guess, sort of pivoting to cost and productivity. I mean, are there any areas that you'd highlight that have been particularly impactful? And do you see that flowing through the P&L yet?

Michael Roman

executive
#25

We saw a number of examples of what we are building in our new operating model and, I would say, with our digital capabilities as we went through 2020. And I highlighted a few of those as we went through the year. Our ability to respond quickly to changes in the marketplace, our cycle times in terms of responding to changes in demand, changes in end market situations, changes in customer-specific demand, that -- we saw that. We saw that come through in our strong cash flow for the year. We were able to respond to the dynamics. And we saw certainly markets that increased demand, and we also saw markets that had significant drop-offs in demand through the year, and we had to manage both ends of that. I think the capabilities that we built out are demonstrating their strengths and their benefits in cash conversion cycles, in our productivity as we manage through those wide range of demand changes throughout the year. So I think those are good examples of how we're starting to see the benefits from the digital and the new operating model -- digital operations and the new operating model. So we are more towards the beginning than the end of that journey, though. We have more capabilities we can deploy. We expect to see greater benefits. There's always more to do, I would say, much more to do, much more opportunity here.

Brendan Luecke

analyst
#26

Okay. Excellent. And then on the topic of innovation, I guess 2 questions here. So the first, I'd be really -- hear a bit of an update on the priority growth platforms. What if -- what type of financial impacts should we be expecting this [ to ensure ]? And do you see these as sort of pure growth initiatives? Or is it sort of a trade-off as certain parts of the portfolio mature? So to what degree is it incremental?

Michael Roman

executive
#27

Well, we've highlighted our priority growth platforms, and that's an area that we've been prioritizing investments for the last several years. We are also prioritizing investments that I highlighted coming through the pandemic and accelerating our efforts as we come into 2021. We see strong growth opportunities continuing in personal safety, home improvement that we've talked about. Health care is an area we see strong growth opportunities as you do move through the recovery in elective procedures, and we are emphasizing those priority growth platforms. This is a group of investment priorities that performed well during 2020. It grew 7% organically for the year despite the market impacts from the pandemic. And we saw 10% growth in Q1 of 2020. So new Filtrete, room air purifiers, biopharma solutions, COVID vaccines and therapeutics, important part of that. Automotive electrification which I talked about, areas like advanced wound care, which complements what we've done with our acquisition of Acelity as well. So they've continued to see strong progress, and we will continue to prioritize priority growth platforms and accelerate our efforts in the trends in the markets, those more attractive markets that I was talking about, as we go through 2021. I think, ultimately, we have strong opportunities to drive sustainable long-term growth by prioritizing the continued focus on our priority growth platforms. They will continue to really deliver strong growth for us. And those new opportunities that we've identified as we've come into 2021.

Brendan Luecke

analyst
#28

Fantastic. And another audience question here, specifically around R&D and prioritization and how that's changed over time. So can you speak a little bit to how your prioritization methods have evolved? What's the role of sort of just your pure R&D versus engineering-led, business-led and how that's been shifting over the last couple of years?

Michael Roman

executive
#29

Yes, Brendan, I'll frame up our investment in R&D and how we think about it, and we can go deeper into any aspect of it, if you'd like. For us, it's -- the first priority for capital allocation is to invest in organic growth opportunities, and R&D is a critical part of that. So our approximately 6% to sales that we invest in R&D., that's our first commitment in capital allocation. When you look at that 6%, it's not spread evenly across all businesses and all aspects of our R&D efforts. It's prioritized. It's prioritized based on where we see the strongest growth opportunities. We invest about 15% of that in longer-term research. Think of it as big R, little d with our corporate laboratories, building technology platforms, supporting some of the priority growth platform like investments more broadly in the businesses where we can leverage fundamental new capabilities we're building at the center. And so that continues to be a priority for investment. That's about advancing our technology. It's about really creating differentiated value, often combining multiple technology platforms in 3M to really make a difference for customers and innovative new solutions driven by focus on both technology and a pull from customers. The other 85% of our R&D is invested in the businesses by the business leadership prioritizing where we see the greatest growth opportunities. And it's not an average across the enterprise. It takes advantage of portfolio view, where do we see the most attractive opportunities for investment. In many cases, it's really necessary to be at the leading edge of innovation, areas like electronics, which have short-cycle design cycle, business spec-in kinds of business models, those are important to continue to focus R&D, not only on near-term solutions for your customer but the next horizon and the horizon after that, really working closely with them. And we've earned the right to work closely with customers to invest not only in today's immediate needs but also their future needs as well. And so that part of our R&D investment is prioritize where we see the best opportunities. And we continue to really value and put an important focus on where we can build new opportunities. We are very good at line extensions, responding to customer needs, improving our product performance, improving the capabilities, giving them the next level of performance they need. It's important while we do that well that we also invest in new penetration opportunities, really new applications to solve new customer problems and also build new businesses. So that's an important part of that overall budget, both the research components and the development components that we are focused on where we can build new capabilities. That's an important driver of growth, as I mentioned.

Brendan Luecke

analyst
#30

So that 85-15 split, has that pretty much been standing model for a long period of time? Or has that been shifting?

Michael Roman

executive
#31

It's been pretty consistent. It's a good balance for us. And whether you talk to the businesses or we talk to our researchers, we've got it in the right place for what we are doing today. And we'll always be looking at do we need to invest more in one area or another as we see opportunities. But it's something that I would say our -- it's been a strong foundation for us in our ability to continue to build differentiated solutions for our customers.

Brendan Luecke

analyst
#32

Okay. Fantastic. I do want to touch briefly on inflation, quite de jure. You've been quite open about 3M's exposure to raw material price increases, I think it's 50% of COGS. How quickly do you believe you're able to pass through these price increases? And is it possible that we'll see sort of headwinds or falling incrementals in the back half of the year as contracts are renegotiated or price levers sort of come into play?

Michael Roman

executive
#33

Well, there's 2 sides of looking at the back half of the year. There's what's going to happen to raw materials, logistics, labor cost inflation. Right now, we're expecting an earnings headwind of $0.30 to $0.50 for the year -- for the full year. No one category makes up more than a few hundred million dollars. So it's -- we're looking at a broader range of feedstocks and, as I said, logistics and labor. I would say this, we have a long history of strong price performance. It reflects our value in the marketplace, our innovation that we've been talking about and how we bring that to customers. And you saw it in Q1. Our selling prices were up 70 basis points. In the face of inflation, we are also taking selling pricing actions, increases. We also are fighting it on both sides. We're driving global sourcing efforts, working on improving yields in our factories, really managing the dynamic. Price will take a little bit of time to implement given the broad and diverse end markets and channels that we serve, the go-to-market models that we have. We expect the impact of our selling prices, really in the face of inflation, to be higher in the second half of the year. So our history of having positive price raw materials performance, we expect that to continue over the long run and as we go through the overall year. So I would say that positions us to have -- overall for 2021 continuing to drive the kind of leverage that we've talked about in the past in our performance. So as we drive growth, delivering 30% to 40% incremental leverage as we manage both sides of that inflation and price RM model.

Bruce Jermeland

executive
#34

Brendan, I was just going to make a quick comment about the near term here. As we have stated, we expect a headwind from price raw material in Q2 of 75 to 125 basis points. As of right now, we're turning to the worst end of that or around 125 basis point impact here in the second quarter.

Michael Roman

executive
#35

Sounds good.

Brendan Luecke

analyst
#36

Okay. Thanks for the color, Bruce. And then one last question on cost here. Would you mind just giving a brief update on the ongoing restructuring efforts. When you sort of layer all that in, do you have a view of run rate OP for the business? I know there's a lot of moving parts here.

Michael Roman

executive
#37

Yes. Let me try to unpack it a little bit. I'll just go back on -- so as you remember, the start of 2020, we launched that global operating model aligned around 4 go-to-market models in our businesses, Safety and Industrial through distribution, Transportation, Electronics, direct OEMs, Health Care and Consumer Retail models. We also built out the enterprise operations organization to manage end-to-end customer service, manufacturing, supply chain. As we've been talking about, there's benefits from that. And we also are learning as we go. And we see even greater opportunities to streamline our operations. And that was the story. That's really what's behind the restructuring efforts that we announced at the end of 2020. And we've implemented restructuring to simplify streamlining the organization across the business groups, functions and geographies. We took a pretax charge, as you recall, in December of $137 million. We took additional small actions in Q1. So now I think we're up to $150 million total pretax charge. Our program is on track. We continue to expect the total charges throughout the restructuring of $250 million to $300 million. We expect taking some pretax charge in Q2, $25 million to $50 million additional, leaving the rest of that to the second half of this year. And just on the savings side of it, we continue to anticipate that we'll deliver annual pretax savings of $200 million to $250 million, with $75 million to $100 million in 2021. So as we move forward, I see -- as we've been talking about, I see meaningful opportunities to improve our operating rigor in those new models, including how we execute, take advantage of those digital strategies we were talking about earlier, data and analytics and further streamline the organization to really drive that focus in that operating performance.

Brendan Luecke

analyst
#38

Excellent. So I'd love to touch briefly on ESG. So I mean you laid out some ambitious targets with investment dollars recently. Can you speak to how you think about ESG as an enduring advantage for 3M?

Michael Roman

executive
#39

Yes. It's a fundamental value to us as a company. Our purpose, applying science to improve lives, includes and always has included advancing sustainability as we serve our customers and the communities where we operate. And over -- for example, over the last 2 decades, we've reduced greenhouse gas emissions by 70% while doubling our revenues. And we've taken some notable steps. We now have our headquarters here in Minnesota fully powered by renewable electricity. We have 40% of our global electricity now from renewable sources, and we're committed to taking that to 100%. So that was foundational. It's -- we take sustainability into our operations, into our innovation, into helping our customers in their own ESG efforts. In February, we announced expanded goals. We made a commitment to invest approximately $1 billion over the next 20 years, both capital and operating investments, to make our operations more efficient, to drive improvements in air, water and waste. And we committed to becoming carbon neutral across our global operations. Importantly for us, we committed to rapidly bend the curve of our emissions, 50% reduction by 2030, 80% by 2040, getting to 100% by '50. That was an important part of our commitment that we had, as we've talked about it, the math and the path and the plan to deliver on it. That was also true of our commitment to reduce water use at our facilities by 25% over the next decade, 10% in 2022, 20% in 2025, bending the curve early in our efforts there. And we are also taking actions on filtration technology that will return even higher-quality water to an environment in our largest operations. So these were big important goals for us. As I said, it was important for us that we had a clear path and that we could commit to bending that curve. We followed up on those announcements, which we made in February. We followed up on that with a commitment to reduce our use of new plastic made from petroleum by 125 million pounds through 2025 or by 2025 with a focus on packaging and product design in our Consumer business. So these are the next priorities for us as we build on that strong value of advancing sustainability in everything that we do.

Brendan Luecke

analyst
#40

Okay. Great. And then, of course, PFAS continues to come up, particularly with the Biden administration. Can you give us an update in terms of how you're thinking about PFAS stewardship? And what, if any, milestones you see on the path towards clarity around the legacy liability?

Michael Roman

executive
#41

Well, I always start here, Brendan. We are focused on managing PFAS guided by 3 principles, and we keep those in front of us: based on sound science, based on corporate responsibility and providing transparency. And we continue to work that way. We work with the EPA and other state authorities to follow through on our ongoing commitments to compliance and environmental stewardship in our manufacturing operations. We're supporting regulation rooted in sound science and continue to believe that the federal regulation will be the path forward that prevents a patchwork of state standards that can make for an uncertainty -- an uncertain environment for communities across the U.S. And as I said just a few minutes ago, we're committed to sustainability, using science to proactively manage PFAS, really, how we work with communities and governments to advance our environmental stewardship. That's an important part of us proactively managing this. From a liability perspective, potential liability, we continue to work closely with our auditors and our advisers and make sure we're accruing for the liability that is both probable and estimable, and that's the challenge. It's what can we see that's probable and estimable to date. And we'll continue to provide disclosure to our investors, to you, on the nature of our PFAS-related litigations in our SEC filings. It's something that we update every quarter. And as I said, we'll continue to monitor and assess the litigations. We'll come back to you as we learn more information that can help impact understanding of what's going on here. And of course, anything that's probable and estimable will be forthcoming about as well. We'll continue to engage in the litigation. We have -- we're anticipating a bellwether case in Michigan sometime later this year. That's the only other action right now or only other planned court action in 2021.

Brendan Luecke

analyst
#42

Okay. Excellent. And then pivoting real briefly, we're coming up in the hour here. I want to touch real quickly on M&A and in sort of your long view going forward. So I mean you've got 2 major deals over the last couple of years, Acelity and M*Modal. How have those been going in terms of the integration? How have they performed through COVID, obviously, both in health care?

Michael Roman

executive
#43

Well, I would say M*Modal, starting with M*Modal, integration has gone very well. It's an ideal fit in our Health Information Systems business. The natural language processing and AI capabilities that M*Modal brings, combined with our coding and classification capabilities in our Health Information Systems business, is helping to position us as a leader in, I would say, eliminating revenue cycle waste and also creating more time for physicians to provide care to patients. This is part of this enabling and helping the shift to value-based care. So it's been, I think, an important strategy for us, and like I said, a good integration, the team is working well with the combined capabilities. Acelity, our largest acquisition to date, is also a great fit in our health care portfolio. It complements, as I mentioned, the priority growth focus on wound care in our Wound Care business, and it's accelerating 3M as a leader in wound care. This is a significant and growing market. It's one of those attractive markets I was talking about. And I would say Acelity has proven to be a good fit. The integration has gone well. Our teams are really taking advantage of the integrated capabilities. We're in a large growing space with trends and demographics. As elective procedures come back and hospitals return to normal, we see growth opportunities coming from the integrated capabilities. We see, I would say, more differentiated capabilities and relevance to health care providers. And especially in areas like post-acute space, it's providing new opportunities for us and an opportunity to drive penetration in a growing area. I think it's -- we've also seen strong synergies being built around our fundamental strengths, the technology capabilities that we bring in 3M Company. And so it's one of those areas where the integration is showing strong signs of being greater than the sum of the parts. Just to note, last year, the Acelity revenue was down in line with our Medical Solutions business impacted by those elective procedures. As those elective procedures improve this year, we expect to see that business turn around. So overall, I'm pleased when you look through that with the way the business has performed since -- really, since we've acquired both of those businesses, I'm pleased with the way they performed.

Brendan Luecke

analyst
#44

Okay. Great. And a quick audience question here. How should investors think about new competition around M*Modal specifically? And I'm speaking to Microsoft with some nuance deal and then often with streamlining RCM?

Michael Roman

executive
#45

Yes. I would say that our HIS business has been a leader in revenue cycle management, clinician solutions, performance management segments of health care for almost 40 years. We continue to drive innovation and leadership there. We saw the importance of cloud-based natural language processing, the AI technologies, the conversational AI technologies in health care. That was behind our acquisition of M*Modal back at the beginning of 2019. And we'll continue to invest in this business to build on those capabilities. This is an opportunity for us to continue to be a leader in the areas of revenue cycle management, the shift of value-based care to improve that patient experience. And improving -- importantly for us, one of the things that's part of our leadership, improving and enhancing documentation, accuracy and efficiency for both providers and payers in that revenue cycle management. So it's an important strategy that we saw when we made the acquisition, and we'll continue to build on it as we go forward.

Brendan Luecke

analyst
#46

Okay. Great. And I guess one last question to wrap it up. We're already at the end of our time here. If you roll the calendar forward 3 years and say we're through the cycle and COVID is hopefully behind us, what are you most excited about? What should investors be most excited about in the 3M story?

Michael Roman

executive
#47

Well, I would say rolling the cycle forward beyond the uncertainty due to the ongoing impacts of COVID-19, we're all looking forward to that, get back to a so-called more normal life. And I would say, many of the things that I'm excited about looking forward to, I talked about today, there are examples of where we see the greatest opportunities to drive growth and leverage our capabilities, our innovation in the next few years. Where can we help advance and grow in the next few years. And we're prioritizing those investments. The pandemic identified new market trends where we're well positioned, and we can work closely with customers. I'm excited about our new operating model and the ability it is providing to be stronger in our engagement and our connection with customers. I think some of the learnings from 2020 in how we innovate with customers and to leverage some of the virtual capabilities together with the close engagement, the intimacy that we have in person, I think those are things I'm excited to see how those can start to add to that -- opportunities that we see in those higher-growth segments and markets. I think we also have an opportunity to further shape and drive inorganic opportunities to complement what we do with our organic investments. And identifying -- and our portfolio strategy is really, first and foremost, about prioritizing where we invest organically. It's also about where can we make acquisitions to complement our capabilities, our fundamental strengths. Good businesses in attractive markets that we can leverage. And so I see opportunities to complement our organic business. And also continue to optimize our portfolio and make the changes in how we operate and changes in our portfolio as needed to maximize the value that we can deliver. So we're still early, as I said, in our new operating model. I also am excited about the capabilities we're building there. So I see there's more that we can do in each of those areas. And I come back to just for a minute on ESG. There's always more we can do on ESG. Environmental stewardship remains a top priority for us as a company. It includes the investments we were talking about. It includes also what we are doing to advance diversity, equity and inclusion. And the commitments we've made, that was an important part of our ESG strategies that we prioritize through 2020 and now are stepping up to in 2021 is what can we do to drive improvements in diversity, equity, inclusion, especially with a focus on underrepresented groups in 3M and also with partners in the community. And so this -- I'm excited... [Technical Difficulty]

Brendan Luecke

analyst
#48

Okay. I think we lost them. Bruce, can you hear me? All right. Mike is frozen.

Michael Roman

executive
#49

And our ability to deliver on our objectives to drive growth at or above the macro, deliver on our improvements in margins, earnings and strong cash flow and continue to really maintain a strong capital structure and financial flexibility that will enable that. So I think that's -- it's a good question, Brendan, to probably close. I think that probably wraps up my closing comments as well.

Brendan Luecke

analyst
#50

Brilliant. Well, thank you so much. We cut out for about 10 seconds there, but -- actually less, maybe 5, but I think the main points landed. I want to thank both of you again for joining us today. Really appreciate the conversation, and a big thank you to our investors as well in the audience. We'll leave it there, and I wish all of you an excellent SDC. Take care.

Bruce Jermeland

executive
#51

Thanks, Brendan.

Michael Roman

executive
#52

Thanks, Brendan.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete 3M Company transcript — plus 248,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to 3M Company earnings transcripts and 248,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.